Concepedia

Wenying Kang

WK

Statistics

Publications

7

Citations

807

H-Index

7

Active since

2019

Affiliations

Jilin Province Tumor Hospital(Current)

Hunan Cancer Hospital

Central South University

Harvard University

First Affiliated Hospital of Xinxiang Medical University

Wenying Kang is an author at Jilin Province Tumor Hospital specializing in medicine, oncology, and combination chemotherapy.

ORCID

Publications per year

2019–2024

7

Publications

7

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

Ying Cheng, Liang Han, Lin Wu et al. · JAMA · 2022 · 456 citations · Full text

, , +17

A novel jamming phase diagram links tumor invasion to non-equilibrium phase separation

Wenying Kang, Jacopo Ferruzzi, Catalina-Paula Spatarelu et al. · iScience · 2021 · 96 citations · Full text

, , +17

Stiffness Restricts the Stemness of the Intestinal Stem Cells and Skews Their Differentiation Toward Goblet Cells

Shijie He, Peng Lei, Wenying Kang et al. · Gastroenterology · 2023 · 72 citations · Full text

, , +12

A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)

Caicun Zhou, Yanping Hu, Ekaterine Arkania et al. · Cancer Cell · 2024 · 60 citations

, , +11

EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial

Quan Zhou, Nynke S. van den Berg, Eben L. Rosenthal et al. · Theranostics · 2021 · 53 citations · Full text

, , +17

1–5 of 7